|
112
|
347
|
5lcjA |
In-gel activity-based protein profiling of a clickable covalent erk 1/2 inhibitor |
|
112
|
331
|
5m4iA |
Complex structure of human protein kinase ck2 catalytic subunit with the inhibitor 4'-carboxy-6,8-chloro-flavonol (flc21) crystallized under high-salt conditions |
|
85
|
279
|
5ko1A |
Pseudokinase domain of mlkl bound to compound 4. |
|
95
|
323
|
5kmlA |
Trka jm-kinase with 1-(5-methyl-3-phenyl-1,2-oxazol-4-yl)-3-[[2-(trifluoromethyl)phenyl]methyl]urea |
|
98
|
297
|
5kx8A |
Irak4-inhibitor co-structure |
|
68
|
292
|
5l2iA |
The x-ray co-crystal structure of human cdk6 and palbociclib. |
|
90
|
315
|
5kmkA |
Trka jm-kinase with 2-fluoro-{n}-[2-(4-fluorophenyl)-6-methyl-3-pyridyl]-4-(trifluoromethyl)benzamide |
|
88
|
298
|
5l2wA |
The x-ray co-crystal structure of human cdk2/cycline and dinaciclib. |
|
78
|
276
|
5knjA |
Pseudokinase domain of mlkl bound to compound 1. |
|
81
|
303
|
5l4qA |
Crystal structure of adaptor protein 2 associated kinase 1 (aak1) in complex with lkb1 (aak1 dual inhibitor) |
|
93
|
323
|
5kmnA |
Trka jm-kinase with 1-(2-methyl-4-phenyl-pyrimidin-5-yl)-3-[[2-(trifluoromethyl)phenyl]methyl]urea |
|
94
|
290
|
5l3aA |
Fragment-based discovery of 6-arylindazole jak inhibitors |
|
72
|
341
|
5kkrC |
Ksr2:mek1 complex bound to the small molecule aps-2-79 |
|
94
|
314
|
5kmmA |
Trka jm-kinase with 1-(2-methyl-4-phenyl-pyrimidin-5-yl)-3-(1-naphthyl)urea |
|
80
|
291
|
5l2sA |
The x-ray co-crystal structure of human cdk6 and abemaciclib. |
|
86
|
298
|
5kmoA |
Trka jm-kinase with 1-(2-methyl-4-phenyl-pyrimidin-5-yl)-3-(2-pyridyl)urea |
|
52
|
283
|
5kkrB |
Ksr2:mek1 complex bound to the small molecule aps-2-79 |
|
94
|
310
|
5kmjA |
Trka jm-kinase with {n}-(2-pyridylmethyl)-2-[2-(2-thienyl)indol-1-yl]acetamide |
|
91
|
265
|
5kupA |
Bruton's tyrosine kinase (btk) with pyridazinone compound 9 |
|
95
|
311
|
5kmiA |
Trka jm-kinase with 1-(9{h}-fluoren-9-yl)-3-(2-methyl-4-phenyl-pyrimidin-5-yl)urea |
|
76
|
291
|
5l2tA |
The x-ray co-crystal structure of human cdk6 and ribociclib. |
|
107
|
348
|
5k5xA |
Crystal structure of human pdgfra |
|
78
|
275
|
5jzjA |
Crystal structure of dclk1-kd in complex with amppn |
|
140
|
465
|
5jn2A |
Crystal structure of tgcdpk1 bound to nvpacu106 |
|
83
|
306
|
5jh6A |
Crystal structure of tl10-92 bound to tak1-tab1 |
|
85
|
305
|
5jfsA |
Crystal structure of trka in complex with pf-00593174 |
|
88
|
325
|
5j9zA |
Egfr-t790m in complex with pyrazolopyrimidine inhibitor 1a |
|
75
|
288
|
5kbrA |
Pak1 in complex with 7-azaindole inhibitor |
|
74
|
288
|
5k0xA |
Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase mer in complex with inhibitor unc2541 |
|
71
|
276
|
5jt2A |
Brafv600e kinase domain in complex with chemically linked vemurafenib inhibitor vem-bisamide |
|
73
|
306
|
5jk3A |
Crystal structure of tl11-128 bound to tak1-tab1 |
|
85
|
305
|
5jfxA |
Crystal structure of trka in complex with pf-06273340 |
|
81
|
301
|
5jebA |
Crystal structure of egfr tyrosine kinase domain with novel inhibitor of active state of her2 |
|
90
|
433
|
5kcvA |
Crystal structure of allosteric inhibitor, arq 092, in complex with autoinhibited form of akt1 |
|
116
|
350
|
5k4iA |
Crystal structure of erk2 in complex with compound 22 |
|
139
|
464
|
5jmsA |
Crystal structure of tgcdpk1 bound to cgp060476 |
|
77
|
296
|
5jq8A |
Crystal structure of cdk2 in complex with inhibitor icec0943 |
|
97
|
307
|
5jgaA |
Crystal structure of human tak1/tab1 fusion protein in complex with ligand 11c |
|
88
|
306
|
5jgdA |
Crystal structure of human tak1/tab1 fusion protein in complex with ligand 12 |
|
81
|
306
|
5j7bA |
The identification and pharmacological characterization of 6-(tert-butylsulfonyl)-n-(5-fluoro-1h-indazol-3-yl)quinolin-4-amine (gsk583), a highly potent and selective inhibitor of rip2 kinase, gsk583 complex |
|
90
|
287
|
5khwA |
Crystal structure of jak1 in complex with adp |
|
78
|
275
|
5k9iA |
Crystal structure of c-src in complex with a covalent lysine probe |
|
83
|
299
|
5k4jA |
Crystal structure of cdk2 in complex with compound 22 |
|
82
|
277
|
5jsmA |
Brafv600e kinase domain in complex with chemically linked vemurafenib inhibitor vem-3-vem |
|
75
|
298
|
5jkgA |
The crystal structure of fgfr4 kinase domain in complex with ly2874455 |
|
84
|
305
|
5jfvA |
Crystal structure of trka in complex with pf-05206283 |
|
88
|
323
|
5j9yA |
Egfr-t790m in complex with pyrazolopyrimidine inhibitor 1b |
|
91
|
289
|
5kbqA |
Pak1 in complex with bis-anilino pyrimidine inhibitor |
|
98
|
347
|
5k5nA |
Crystal structure of gsk-3beta complexed with pf-04802367, a highly selective brain-penetrant kinase inhibitor |
|
83
|
273
|
5jrqA |
Brafv600e kinase domain in complex with chemically linked vemurafenib inhibitor vem-6-vem |
